Cala Health occupies a well-defined niche in peripheral neuromodulation with its wrist-worn TAPS therapy, offering patient-specific stimulation for essential tremor without invasive procedures. With FDA clearance and commercial traction, it sits ahead of most wearable neuromodulation startups, though its indication-specific focus limits platform extensibility compared to broader neuromodulation systems.